Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes-Reference-Cited by-同舟云学术

Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes

Published:2023-10-03 Issue:14 Volume:101 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Boon Baayla D.C.¹^ORCID,Labuzan Sydney A.¹^ORCID,Peng Zhongwei¹^ORCID,Matchett Billie J.¹^ORCID,Kouri Naomi¹,Hinkle Kelly M.¹,Lachner Christian¹,Ross Owen A.¹,Ertekin-Taner Nilufer¹,Carter Rickey E.¹,Ferman Tanis J.¹,Duara Ranjan¹^ORCID,Dickson Dennis W.¹^ORCID,Graff-Radford Neill R.¹,Murray Melissa E.¹^ORCID

Affiliation:

1. From the Department of Neuroscience (B.D.C.B., S.A.L., B.J.M., N.K., K.M.H., O.A.R., N.E.-T., D.W.D., M.E.M.), Department of Quantitative Health Sciences (Z.P., R.E.C.), Department of Neurology (C.L., N.E.-T., N.R.G.-R.), and Department of Psychiatry & Psychology (C.L., T.J.F.), Mayo Clinic, Jacksonville; and Wien Center for Alzheimer's Disease and Memory Disorders (R.D.), Mount Sinai Medical Center, Miami Beach, FL.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207685

Reference48 articles.

1. Neuropathological stageing of Alzheimer-related changes

2. Phases of Aβ-deposition in the human brain and its relevance for the development of AD

3. Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

4. Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

5. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amygdala-predominant α-synuclein pathology exacerbates hippocampal neuron loss in Alzheimer’s disease;2024-06-27

2. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease;JAMA Neurology;2024-06-01

3. Divergent Neurodegenerative Patterns: Comparison of FDG-PET- and MRI-based Alzheimer’s Disease Subtypes;2024-05-31